Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21Genitourinary 10Breast 10Gynecologic 6Plasma cell 5Thoracic 3Lymphoid 3Other hematologic neoplasm 2Tumor-Agnostic 1Other 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Neoplasms 1Mucositis 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Curcumin × Other × Clear all
NCT02300727 2019-05-31

Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy

Aurora BayCare Medical Center

Phase 1/2 Terminated
6 enrolled 4 charts
Other

Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡